Other than a safe dividend yield of 2.4%, the blue-chip stock also offers solid long-term returns potential at current levels ...

Released on Friday, February 7, the January jobs report showed resilience in the labor market with higher-than-expected wage ...

Capital expenditures among retailers are projected to reach $55 billion, marking an average of around 7% year-on-year growth ...

Jim Cramer, host of Mad Money, made a compelling argument on Monday that parents should begin investing for their children as ...

C3.ai, Inc. is riding the AI coattails from Palantir Technologies, but the relative value is remarkable. Click here to read ...

Palantir's growth is undeniable, but analysis reveals excessive valuation despite strong performance. Click here to read an ...

Here are seven of the best Treasury ETFs to buy in 2025: ...

Apple (NASDAQ: AAPL) has been surprisingly solid over the past few months and has continued on a steady trajectory. Most ...

Nvidia (NASDAQ:NVDA) was rocked by Chinese artificial intelligence lab DeepSeek releasing an AI model that was more efficient ...

Rachel Reeves is desperate for her plan for economic growth to work - but meddling with the tax benefits of cash ISAs is ...

Smithson Investment Trust, a small- and mid-cap fund, has struggled to live up to lofty expectations, says Rupert Hargreaves.

The biotechnology sector is filled with high-potential growth stocks. With advancements in artificial intelligence (AI), biotech remains at the cutting edge of medical and scientific innovation, ...